(+961) 1 421 000 ext mabel.aoun@usj.edu.lb
Dr Mabel Aoun graduated in 2004 as a nephrologist from the Saint-Joseph University of Beirut completed her fellowship in nephrology, kidney transplantation renal pathology in Paris. She was the head of Department of Nephrology at Saint-Georges Ajaltoun Hospital in Lebanon between 2006 2022. In September 2022, she moved to France and has been practicing at AUB Santé, Lorient. She is currently an Associate Professor at the faculty of medicine of Saint-Joseph University of Beirut and she is involved in mentoring the medical theses of medical students. Her main academic lectures target chronic kidney disease, drugs and kidney, cystic kidney diseases, hypertension emergencies, acid-base disturbances, renal anemia and hyperuricemia. She is the author of more than 40 peer-reviewed publications, first author of 23, a reviewer for several international journals and editor for Nephrology Dialysis Transplantation, BMC Nephrology and PLOS ONE. She led the development of a national policy at the Lebanese Ministry of Public Health upgrading water quality and guidelines in Lebanese hemodialysis units in 2014. In June 2020, she received her Master of Public Health and Health Management and Policy from the American University of Beirut. She received her diploma in systematic reviews and meta-analysis from the Paris-Cite University in France in June 2023. She has a strong commitment to research in nephrology, particularly in areas where she has good expertise such as hemodialysis, chronic kidney disease, hypertension, epidemiology and public health.
Degrees | University | Country | Year |
---|---|---|---|
NDT Editorial Fellowship | European Renal Organisation | Italie | 2024 |
DUTER | Université de Strasbourg | France | 2024 |
Revues systématiques et métaanalyses de la santé | Université Paris Cité | France | 2023 |
Good Clinical Practice | Université de Rennes I | France | 2023 |
Diplôme Universitaire d'éducations en sciences de la santé | Saint Joseph University of Beirut | Lebanon | 2019 |
Renal Pathology | Université Pierre et Marie Curie (Paris VI) | France | 2005 |
Nephrology | Saint Joseph University of Beirut | Lebanon | 2004 |
Docteur en médecine | Saint Joseph University of Beirut | Lebanon | 2000 |
Professional Experience | Organization | Start date | End date |
---|---|---|---|
Nephrologist | AUB SANTE | 24/09/2022 | 01/11/2024 |
Head of Department of Nephrology | Hôpital Saint-Georges Ajaltoun | 01/02/2006 | 30/06/2022 |
Medecine and Health
Anemia chronic kidney disease Anemia acute kidney injury Erythrocytosis chronic kidney disease Vascular calcifications hemodialysis Quality of life and hemodialysis Fatigue and hemodialysis Headache and hemodialysis Social determinants of health and hemodialysis Satisfaction of nephrologists Environmental factors and chronic kidney disease Hypertension and climate change Cost of illness of chronic kidney disease
1-Pearls of NDT, Lecture, ERA Congress, Stockholm 2024. 2-Twice against Thrice weekly Hemodialysis: the TATH trial. Oral communication, ERA Congress, Stockholm 2024. 3-Reimagining health systems. Oral presentation at the HSR2020, Health Systems Global (HSG). Dubai, March 2021. 4-Risk Factors for Vascular Calcifications in Hemodialysis Patients: to What Extent is Vitamin K Deficiency involved? Oral communication. ERA-EDTA congress- Madrid May 2017. 5-Aoun M, Jadoul M, Anders HJ. Erythrocytosis chronic kidney disease. AJKD. 2024. 6-Jadoul M, Aoun M, Masimango M. The major global burden of chronic kidney disease. Lancet Global Health. 2024. 7-Aoun M, Koubar S. Global dialysis perspective: Lebanon. Kidney360, July 2023. 8-Aoun M, Sleilaty G, Abou Jaoude S, Chelala D, Moussa R. How do Lebanese patients perceive the ideal doctor based on the CanMEDS competency framework? BMC Med Educ. 201919:399. 9-Aoun M, Karam R, Sleilaty G, Antoun L, Ammar W. Iron deficiency across chronic kidney disease stages: is there a reverse gender pattern? PLOS ONE. 2018 doi.org/10.1371/journal.pone.0191541 10-38. Aoun M, Makki M, Azar H, Matta H, Chelala D. High Dephosphorylated-Uncarboxylated MGP in Hemodialysis patients: risk factors response to vitamin K2, a pre-post intervention clinical trial. BMC Nephrology. 201718:191.
• ORCID